Bubs (ASX: BUB) will be doing its part to help struggling US families feed their babies amid a severe formula shortage. The company's stock is currently up more than 20% in pre-market.Bubs received approval from the US Food and Drug Administration (FDA) on Saturday, allowing it to provide at least 1.25m cans of infant formula products including Stage 1 and 2 Bubs Organic Grass Fed, Bubs Supreme A2 Beta-Casein Protein and Bubs Easy-digest Goat Milk.According to Bubs, 500,000 tins are ready for immediate export and the remaining 750,000 are scheduled for completion in the coming months.
Bubs (ASX: BUB) will be doing its part to help struggling US...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $142.9M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.5¢ | $220.7K | 1.409M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 653984 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 1678229 | 23 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| BUB (ASX) Chart |